Cargando…
Nanomedicines in renal transplant rejection – focus on sirolimus
Nanomedicine, known as the application of nanotechnology in medicine, has been applied to overcome the problems of poor bioavailability, in vitro and in vivo stability, and targeted delivery in the preparation of pharmaceutical products. Sirolimus, a water-insoluble immunosuppressant, has been formu...
Autores principales: | Shen, Li-Jiuan, Wu, Fe-Lin Lin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673820/ https://www.ncbi.nlm.nih.gov/pubmed/17722509 |
Ejemplares similares
-
Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020) -
Hemopericardium in a Sirolimus-Treated Renal Transplant Patient
por: Groudan, Kevin, et al.
Publicado: (2020) -
Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
por: Hedley, Adam J., et al.
Publicado: (2008) -
Sirolimus-induced interstitial pneumonitis in a renal transplant recipient
por: Kanaan, Nada, et al.
Publicado: (2008) -
Nanomedicines in the treatment of acromegaly: focus on pegvisomant
por: Roelfsema, Ferdinand, et al.
Publicado: (2006)